We are live on ! Find out more
MVM

Medicxi Ventures Management Portfolio holdings

AUM $982M
1-Year Est. Return 210.17%
This Fund
S&P 500
This Quarter Est. Return
-17.04%
1 Year Est. Return
+210.17%
3 Year Est. Return
+787.54%
5 Year Est. Return
+404.19%
10 Year Est. Return
AUM
$438M
AUM Growth
-$91.4M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
5
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNTA
1
DELISTED
Centessa Pharmaceuticals
CNTA
$287M 65.59%
19,963,157
NAMS icon
2
NewAmsterdam Pharma
NAMS
$3.25B
$58.7M 13.42%
2,869,565
PHAT icon
3
Phathom Pharmaceuticals
PHAT
$708M
$46.8M 10.69%
7,464,572
RAPT
4
DELISTED
RAPT Therapeutics
RAPT
$27.3M 6.23%
2,794,000
AURA icon
5
Aura Biosciences
AURA
$725M
$17.8M 4.07%
3,039,892

Similar funds

Medicxi Ventures Management's Q1 2025 Portfolio in Review

As of Q1 2025, Medicxi Ventures Management held 5 positions worth $438M, down 17% from $529M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2025: portfolio turnover was 0%. Medicxi Ventures Management opened no new positions and made no exits, leaving the 5-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Medicxi Ventures Management's ten largest holdings make up 100% of its $438M portfolio in Q1 2025.
  • Medicxi Ventures Management opened 0 new positions and closed 0 in Q1 2025.
  • Medicxi Ventures Management's portfolio value fell 17% quarter-over-quarter to $438M.

Based on Medicxi Ventures Management's 13F filing for Q1 2025, filed 11 Apr 2025.